Laserfiche WebLink
Table 1,0ccupational exposure limits <br />for asbestos <br />Exposure limits <br />MWW* <br />OSHA PEL TWA 0.2 <br />Action level 0.1 <br />NIOSH REL TWA (Ca)t 0.1 <br />ACGIH Tus TWA (Ala)§ 20 <br />Chrysotile 0.5 <br />Amosite 0.2 <br />Crocidolite 2.0 <br />Other forms <br />* Fibers greater than 5 µm in length -a potent <br />human car- <br />t (Ca): NIOSH recommends treating po <br />cinogen. <br />§ (Ala): Human carcinogen with an assigned TLV®. <br />HEALTH HAZARD INFORMATION <br />• Routes of exposure <br />Asbestos may cause adverse health effects following exposure <br />via inhalation or ingestion. <br />• Sumnvary of toxicology <br />1 �ects on animals: Single intrapleural injections of asbestos <br />in rats, rabbits, and hamsters produced mesothelioma (cancer <br />of the chest or abdominal linings). In rats, chronic inhalation <br />or oral administration of asbestos produced cancers of the <br />All forms <br />lungs, stomach, kidneys; liver, or mammary glands. <br />of asbestos were found to be carcinogenic in treated animals. <br />2. Effects on humans: Exposure to asbestos has been found to <br />significantly increase the risks of contracting asbestosis, lung <br />cancer, and mesothelioma. <br />• Signs and symptoms of exposure <br />1. Short-term (acute): Exposure to asbestos can cause short- <br />ness of breath, chest or abdominal pain, and irritation of the <br />skin and mucous membranes. <br />2. Long-term (chronic): Exposure to asbestos can cause <br />reduced pulmonary function, breathing difficulty, dry cough, <br />broadening and thickening of the ends of the fingers, and bluish <br />discoloration of the skin and mucous membranes. <br />IA <br />RECOMMENDED <br />and biologic monitoring, medical screening, and morbidity and <br />mortality data. This analysis may provide information about <br />the relatedness of adverse health effects and occupational ex- <br />posure that cannot be discerned from results in individual <br />workers. Sensitivity, specificity, and predictive values of bio- <br />logic monitoring and medical screening tests should be evalu- <br />ated on an industrywide basis prior to application in any given <br />worker group. Intrinsic to a surveillance program is the dis- <br />semination of summary data to those who need to know, in- <br />cluding employers, occupational health professionals, <br />potentially exposed workers, and regulatory and public health <br />agencies. • <br />• Preplacement medical evaluation <br />Prior to placing a worker in a job with a potential for exposure <br />to asbestos, the physician should evaluate and document the <br />workers baseline health status with thorough medical, environ- <br />mental, and occupational histories, a physical examination, and <br />physiologic and laboratory tests appropriate for the anticipat- <br />ed occupational risks. These should concentrate on the func- <br />tion and integrity of the respiratory system using the principles <br />and methods recommended by NIOSH and the American <br />Thoracic Society, (ATS). <br />A preplacement medical evaluation is recommended in order <br />to detect and assess preexisting or concurrent conditions which <br />may be aggravated or result in increased risk when a worker <br />is exposed to asbestos at or below the NIOSH REL. The ex- <br />amining physician should consider the probable frequency, in- <br />tensity, <br />ntensity, and duration of exposure, as well as the nature and <br />degree of the condition, in placing such a worker. Such con- <br />ditions, which should not be regarded as absolute contraindi- <br />cations to job placement, include cigarette smoking, <br />preexisting asbestos-related disease, and significant breathing <br />impairment due to preexisting chronic lung diseases. In addi- <br />tion to the medical interview and physical examination, the <br />means to identify these conditions may include the methods <br />recommended by NIOSH and ATS. <br />• Periodic medical screening and/or biologic monitoring <br />Occupational health interviews and physical examinations <br />should be performed at regular intervals. Additional examina- <br />tions may be necessary should a worker develop symptoms that <br />may be attributed to exposure to asbestos. The interviews. ex- <br />• Medical surveillance Program at and appropriate medical screening and/or biologic <br />ssive <br />Workers with potential exposures tohazards o medicrveillance decrease or adverse trend in the Phys ologictng functioan n of the <br />be monitored in a systemaatprogram <br />and disease. respiratory system as compared to the baseline status of the in - <br />intended to prevent or control occupational injury p values for a suitable refer - <br />The program should include education of employers and work dividual worker or to the expected <br />ers about work-related hazards, placement of workers in jobs ence population. The following testsshoouul d evale used ua- <br />that do not jeopardize their safety and health, earliest possi- interpreted according to standardized procedures <br />ble detection of adverse health effects, and referral of workers tion criteria recommended by NIOSH and ATS: standardized <br />for diagnostic confirmation and treatment. The occurrence of questionnaires, tests of lung function, and chest X-rays. <br />disease (a "sentinel health event, SHE) or other work-related <br />adverse health effects should prompt immediate evaluation of <br />primary preventive measures (e.g., industrial hygiene monitor- <br />ing, engineering controls, and personal protective equipment). <br />A medical surveillance program is intended to supplement, not <br />replace, such measures. <br />A medical surveillance program should include systematic col- <br />lection and epidemiologic analysis of relevant environmental <br />E <br />® Medical practices recommended at the time of JUU h ans- <br />fer or termination <br />and occupational history inter - <br />The medical, environmental, <br />views, the physical examination, and selected physiologic and <br />laboratory tests which were conducted at the time of placement <br />should be repeated at the time of job transfer or termination. <br />Any changes in the worker's health status should be compared <br />to those expected for a suitable reference pop <br />11 <br />